Jeremiah L. Deneve
Papers
4
Total Citations
91
H-Index
3
About
Jeremiah L. Deneve is a surgical oncologist whose research focuses on minimally invasive abdominal surgery, with particular expertise in hepatic and pancreatic procedures. His work has made significant contributions to understanding the outcomes and risk factors associated with unplanned conversions from minimally invasive to open surgery — a critical clinical challenge that directly impacts patient recovery and resource utilization. Deneve's most influential contributions draw on large-scale national datasets, most notably the ACS-NSQIP database, to identify predictors of surgical conversion and quantify their downstream implications. His 2017 analysis of unplanned conversions during minimally invasive hepatectomy has garnered 45 citations, establishing it as a key reference in hepatobiliary surgery literature. Complementing this work, his 2018 study on minimally invasive pancreatectomy conversions has accumulated 39 citations, further cementing his reputation as a leading voice in this niche but clinically vital area. His more recent 2023 investigation into distal pancreatectomy for pancreatic adenocarcinoma reflects an ongoing commitment to refining oncologic surgical practice. Overall, Deneve's population-level, data-driven approach provides surgeons with actionable evidence to better counsel patients and optimize operative decision-making in complex abdominal cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4